Skip to main content
Addgene

pOGS539_haPD-1
(Plasmid #226716)

Print

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 226716 Standard format: Plasmid sent in bacteria as agar stab 1 $85
Add to Cart

Backbone

  • Vector backbone
    OGS539
  • Backbone manufacturer
    Sigma-Aldrich
  • Backbone size w/o insert (bp) 6846
  • Total vector size (bp) 7883
  • Vector type
    Yeast Expression
  • Selectable markers
    Blasticidin

Growth in Bacteria

  • Bacterial Resistance(s)
    Kanamycin, 50 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    High affinity PD-1 microbody
  • Alt name
    haPD-1
  • Species
    Synthetic
  • Insert Size (bp)
    1037
  • Promoter pTEF1
  • Tags / Fusion Proteins
    • HA tag (N terminal on insert)
    • Mating factor alpha secretion signal (N terminal on insert)

Cloning Information

  • Cloning method Gibson Cloning
  • 5′ sequencing primer CATATCACATAGGAAGCAACAG
  • 3′ sequencing primer CTACGATACCGATAGAGATGG
    • (Common Sequencing Primers)

Resource Information

  • A portion of this plasmid was derived from a plasmid made by
    Gene information received directly from Aaron Ring, MD PhD, Fred Hutch Cancer Center

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pOGS539_haPD-1 was a gift from Gautam Dantas (Addgene plasmid # 226716 ; http://n2t.net/addgene:226716 ; RRID:Addgene_226716)

  • For your References section:

    A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden. Rebeck ON, Wallace MJ, Prusa J, Ning J, Evbuomwan EM, Rengarajan S, Habimana-Griffin L, Kwak S, Zahrah D, Tung J, Liao J, Mahmud B, Fishbein SRS, Ramirez Tovar ES, Mehta R, Wang B, Gorelik MG, Helmink BA, Dantas G. Cell Chem Biol. 2024 Nov 16:S2451-9456(24)00452-5. doi: 10.1016/j.chembiol.2024.10.013. 10.1016/j.chembiol.2024.10.013 PubMed 39571582
Related items: